Maria Glymour
Profiles

Maria Glymour, SD

Chair and Professor, Epidemiology - Boston University School of Public Health

Biography

Research Interests
- Alzheimer's disease and related causes of cognitive aging and dementia
- Social determinants of health and health equity
- Social policies and health
- Causal inference in social epidemiology and dementia research

My research focuses on how social factors experienced across the lifecourse, from infancy to adulthood, influence cognitive function, dementia, stroke, and other health outcomes in old age. I am especially interested in education and other exposures amenable to policy interventions. The health of current cohorts of elderly individuals in the US reflect a lifetime of social exposures, including educational experiences shaped by major changes in schooling policies. Education is especially interesting because it is such a powerful predictor of health and historically, access to education has frequently been restricted based on race, gender, and other socially enforced criteria. One thread of my research examines how changes in schooling laws and school quality in the 20th century might have influenced the health and cognitive outcomes of current cohorts of elderly, including adults subject to race-based school segregation. Our results suggest that extra schooling has substantial benefits for memory function in the elderly. I have also worked on the influence of "place" on health, for example to understand the excess stroke burden for individuals who grew up in the US Stroke Belt. In a project with colleagues including Drs. Rachel Whitmer, Elizabeth Rose Mayeda, and Paola Gilsanz, we are continuing a unique multi-ethnic cohort of older adults in Northern California, with a wealth of lifecourse biological and social data to offer insight into the reasons for racial/ethnic differences in Alzheimer's and dementia risk (https://rachelwhitmer.ucdavis.edu/khandle).

A separate theme of my research focuses on overcoming methodological problems encountered in analyses of social determinants of health, Alzheimer's disease, and dementia. For many reasons, research focusing on lifecourse epidemiology as well as cognitive aging introduces substantial methodological challenges. Sometimes, these are conceptual challenges, and clear causal thinking can help! Many of these challenges are being addressed in the MELODEM (MEthods in LOngitudinal research on DEMentia) initiative, an international group of researchers focusing on analytic challenges in research on dementia and cognitive aging. MELODEM has working group phone calls on the first and third Thursdays of the month, open to all (https://sites.bu.edu/melodem/). My group works with numerous colleagues on methods to improve measurement, including crosswalking across data sets. For example, in work with Dr. Zeki Al Hazzouri, we are linking data sets with detailed information at different lifecourse periods -- e.g., childhood, early adulthood, and later adulthood -- to better evaluate long-term effects of exposures at specific sensitive ages. In work with Dr. Cathy Schaefer, Ron Krauss, and many others, we are fielding emulated trial designs in the large, diverse Kaiser Permanente Northern California cohort. This setting is exceptional for emulated trial designs because of the large size, long follow-up, and combination of high-quality clinical data plus social and genetic information for large groups of study participants.

I have advocated the use of causal directed acyclic graphs (DAGs) as a standard research tool to represent our causal hypotheses and help elucidate potential biases in proposed analyses. In other cases, the methodological problems require more analytical solutions that have been developed elsewhere in epidemiology or in other disciplines, but are rarely applied to these research questions. Instrumental variables analyses of natural or induced experiments are one promising example. Genetic variations have recently been advanced as possible instrumental variables to estimate the health effects of a wide range of phenotypes, an approach sometimes called “Mendelian Randomization.” Using genetic polymorphisms as instrumental variables could provide a very powerful tool for social epidemiology, but the inferences from such analyses rest on strong assumptions. Thus I am currently working with a team to explore approaches to evaluating the plausibility of those assumptions in applications for social epidemiology.

Students and post-doctoral fellows interested in research collaborations related to my work are welcome to send me an email directly or contact Robin Hyatt, rshyatt@bu.edu, who handles my calendar.

Education

  • Harvard School of Public Health, SD Field of Study: Epidemiology
  • University of Chicago, AB Field of Study: Biology
  • Harvard School of Public Health, SM/ScM Field of Study: Epidemiology

Classes Taught

  • SPHEP912

Publications

  • Published on 10/1/2024

    Komura T, Tsugawa Y, Mayeda ER, Glymour MM, Inoue K. Association of Cardiovascular Events With Spouse's Subsequent Dementia. JAMA Neurol. 2024 Oct 01; 81(10):1098-1099. PMID: 39186285.

    Read At: PubMed
  • Published on 9/3/2024

    Mobley TM, Hayes-Larson E, Wu Y, Peterson RL, George KM, Gilsanz P, Glymour MM, Thomas MD, Barnes LL, Whitmer RA, Mayeda ER. School racial/ethnic composition, effect modification by caring teacher/staff presence, and mid-/late-life depressive symptoms: findings from the Study of Healthy Aging in African Americans. Am J Epidemiol. 2024 Sep 03; 193(9):1253-1260. PMID: 38634611.

    Read At: PubMed
  • Published on 9/3/2024

    Jawadekar N, Zimmerman S, Lu P, Riley AR, Glymour MM, Kezios K, Al Hazzouri AZ. A critique and examination of the polysocial risk score approach: predicting cognition in the Health and Retirement Study. Am J Epidemiol. 2024 Sep 03; 193(9):1296-1300. PMID: 38775285.

    Read At: PubMed
  • Published on 8/9/2024

    Hayes-Larson E, Zhou Y, Rojas-Saunero LP, Shaw C, Seamans MJ, Glymour MM, Murchland AR, Westreich D, Mayeda ER. Methods for extending inferences from observational studies: considering causal structures, identification assumptions, and estimators. Epidemiology. 2024 Aug 09. PMID: 39120938.

    Read At: PubMed
  • Published on 8/3/2024

    Khadka A, Hebert JL, Glymour MM, Jiang F, Irish A, Duchowny KA, Vable AM. Quantile regressions as a tool to evaluate how an exposure shifts and reshapes the outcome distribution: A primer for epidemiologists. Am J Epidemiol. 2024 Aug 03. PMID: 39098821.

    Read At: PubMed
  • Published on 8/3/2024

    Sims KD, Glymour MM, Ncube CN, Willis MD. Improving spatial exposure data for everyone - lifecourse social context and ascertaining residential history. Am J Epidemiol. 2024 Aug 03. PMID: 39098825.

    Read At: PubMed
  • Published on 7/30/2024

    Kim MH, Frøslev T, White JS, Glymour MM, Illango SD, Sørensen HT, Pedersen L, Hamad R. Kim et al. Respond to "Dispersal policies, neighborhood disadvantage, and refugee health in a Nordic context". Am J Epidemiol. 2024 Jul 30. PMID: 39086093.

    Read At: PubMed
  • Published on 7/25/2024

    Gutierrez S, Whitmer RA, Soh Y, Peterson R, George KM, Lor Y, Barnes LL, Mayeda ER, Allen IE, Torres JM, Glymour MM, Gilsanz P. School-based racial segregation, social support, and late-life cognitive function in the Study of Healthy Aging in African Americans (STAR). Alzheimers Dement. 2024 Jul 25. PMID: 39054568.

    Read At: PubMed
  • Published on 7/15/2024

    Wang J, Ackley S, Woodworth DC, Sajjadi SA, Decarli CS, Fletcher EF, Glymour MM, Jiang L, Kawas C, Corrada MM. Associations of Amyloid Burden, White Matter Hyperintensities, and Hippocampal Volume With Cognitive Trajectories in the 90+ Study. Neurology. 2024 Aug 13; 103(3):e209665. PMID: 39008782.

    Read At: PubMed
  • Published on 7/5/2024

    Kezios KL, Zimmerman SC, Buto PT, Rudolph KE, Calonico S, Zeki Al Hazzouri A, Glymour MM. Overcoming Data Gaps in Life Course Epidemiology by Matching Across Cohorts. Epidemiology. 2024 Sep 01; 35(5):610-617. PMID: 38967975.

    Read At: PubMed

News & In the Media